CASK | Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MAOA | Monoamine oxidase A | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
MAOB | Monoamine oxidase B | Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
RP2 | Retinitis pigmentosa 2 (X-linked recessive) | Disease related genes
| | | | | Mixed |
RGN | Regucalcin | Enzymes Plasma proteins
| | | | | Group enriched |
NDUFB11 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
RBM10 | RNA binding motif protein 10 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CDK16 | Cyclin-dependent kinase 16 | Enzymes
| | | | | Expressed in all |
USP11 | Ubiquitin specific peptidase 11 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
SYN1 | Synapsin I | Disease related genes Plasma proteins
| | | | | Tissue enriched |
TIMP1 | TIMP metallopeptidase inhibitor 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ELK1 | ELK1, member of ETS oncogene family | RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
SPACA5 | Sperm acrosome associated 5 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
SPACA5B | Sperm acrosome associated 5B | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
WDR13 | WD repeat domain 13 | | | | | | Expressed in all |
WAS | Wiskott-Aldrich syndrome | Cancer-related genes Disease related genes
| | | | | Mixed |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
HDAC6 | Histone deacetylase 6 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
PQBP1 | Polyglutamine binding protein 1 | Disease related genes
| | | | | Expressed in all |
TFE3 | Transcription factor binding to IGHM enhancer 3 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
PRAF2 | PRA1 domain family, member 2 | Predicted membrane proteins
| | | | | Expressed in all |
GPKOW | G patch domain and KOW motifs | | | | | | Expressed in all |
SYP | Synaptophysin | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
PAGE1 | P antigen family, member 1 (prostate associated) | | | | | | Tissue enriched |
AKAP4 | A kinase (PRKA) anchor protein 4 | Cytoskeleton related proteins
| | | | | Tissue enriched |
CCNB3 | Cyclin B3 | | | | | | Tissue enhanced |
CXorf67 | Chromosome X open reading frame 67 | | | | | | Group enriched |
GSPT2 | G1 to S phase transition 2 | | | | | | Expressed in all |
XAGE2B | X antigen family, member 2B | | | | | | Tissue enriched |
XAGE2 | X antigen family, member 2 | | | | | | Tissue enriched |
SSX2 | Synovial sarcoma, X breakpoint 2 | Cancer-related genes Disease related genes
| | | | | Tissue enriched |
SMC1A | Structural maintenance of chromosomes 1A | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PHF8 | PHD finger protein 8 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
GNL3L | Guanine nucleotide binding protein-like 3 (nucleolar)-like | | | | | | Expressed in all |
MAGED2 | Melanoma antigen family D, 2 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
PAGE2B | P antigen family, member 2B | | | | | | Tissue enriched |
PAGE2 | P antigen family, member 2 (prostate associated) | | | | | | Tissue enriched |
PAGE5 | P antigen family, member 5 (prostate associated) | | | | | | Tissue enriched |
UBQLN2 | Ubiquilin 2 | Disease related genes Plasma proteins
| | | | | Expressed in all |
MSN | Moesin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
VSIG4 | V-set and immunoglobulin domain containing 4 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
KIF4A | Kinesin family member 4A | | | | | | Mixed |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
IL2RG | Interleukin 2 receptor, gamma | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
MED12 | Mediator complex subunit 12 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
NLGN3 | Neuroligin 3 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GJB1 | Gap junction protein, beta 1, 32kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
NONO | Non-POU domain containing, octamer-binding | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |